Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services is a global CDMO offering cutting-edge ADC platform consists of site-specific conjugation and novel linker technology. We have developed an innovative conjugation method based on proprietary Fc-affinity peptides that provides significant advantages for next generation ADC and bioconjugate; 1) enhanced therapeutic window with precise DAR control and highly-stable linker platform; 2) straightforward and cost-effective conjugate process, requiring no genetic modification or enzymes; and 3) dual-payload and other flexible drug designs including DAR-1.
